In this review, we will focus on aldose reductase (AR), its possible link to the cardiovascular complications of diabetes mellitus and the potential impact of pharmacological inhibition of AR on cardiovascular complications of diabetes. The gene discussed is AR; the disease is diabetes mellitus.